Founded in
2019
SHORT DESCRIPTION:
Cellmabs is focused on researching and developing innovative biopharmaceuticals for the treatment of cancer. The team is comprised of renowned scientists and international experts in the field of glycoimmunology and oncology.
LONG DESCRIPTION:
Lisbon
2019
$ 2.5 Millions - $ 5 Millions
Add a review